{"entity":{"type":"insider","cik":"0001594857","url":"/insider/0001594857","json_url":"/insider/0001594857.json","name":"Tung Roger D","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":6,"n_filings":6,"first":"2016-05-12","last":"2023-01-09","span_basis":"filed_date"},"name_variants":[{"name":"Tung Roger D","source":"filing","n_filings":6,"first_seen":"2016-05-12","last_seen":"2023-01-09"}],"transactions":[{"id":8435400,"accession":"0001209191-23-002556","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-002556","line_url":"/filing/0001209191-23-002556#line-1","is_derivative":false,"issuer_cik":"0001367920","issuer_name":"CONCERT PHARMACEUTICALS, INC.","issuer_ticker":"CNCE","issuer_name_source":null,"issuer_url":"/issuer/0001367920","owner_cik":"0001594857","owner_name":"Tung Roger D","owner_display_name":"Tung Roger D","owner_url":"/insider/0001594857","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9240.0,"shares_display":"9,240","price_per_share":7.24,"price_display":"7.24","price_state":"stated","total_value":66897.6,"total_display":"66,897.60","total_whole":"66,898","shares_owned_after":971018.0,"shares_owned_after_display":"971,018","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-06","filed_date":"2023-01-09","scope":"insider"},{"id":6977167,"accession":"0001209191-22-010075","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-010075","line_url":"/filing/0001209191-22-010075#line-1","is_derivative":false,"issuer_cik":"0001367920","issuer_name":"CONCERT PHARMACEUTICALS, INC.","issuer_ticker":"CNCE","issuer_name_source":null,"issuer_url":"/issuer/0001367920","owner_cik":"0001594857","owner_name":"Tung Roger D","owner_display_name":"Tung Roger D","owner_url":"/insider/0001594857","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13480.0,"shares_display":"13,480","price_per_share":3.09,"price_display":"3.09","price_state":"stated","total_value":41653.2,"total_display":"41,653.20","total_whole":"41,653","shares_owned_after":980258.0,"shares_owned_after_display":"980,258","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-15","filed_date":"2022-02-16","scope":"insider"},{"id":6094446,"accession":"0001209191-22-002405","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-22-002405","line_url":"/filing/0001209191-22-002405#line-3","is_derivative":false,"issuer_cik":"0001367920","issuer_name":"CONCERT PHARMACEUTICALS, INC.","issuer_ticker":"CNCE","issuer_name_source":null,"issuer_url":"/issuer/0001367920","owner_cik":"0001594857","owner_name":"Tung Roger D","owner_display_name":"Tung Roger D","owner_url":"/insider/0001594857","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9240.0,"shares_display":"9,240","price_per_share":3.09,"price_display":"3.09","price_state":"stated","total_value":28551.6,"total_display":"28,551.60","total_whole":"28,552","shares_owned_after":784838.0,"shares_owned_after_display":"784,838","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-06","filed_date":"2022-01-07","scope":"insider"},{"id":5480896,"accession":"0001209191-21-069812","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-069812","line_url":"/filing/0001209191-21-069812#line-2","is_derivative":false,"issuer_cik":"0001367920","issuer_name":"CONCERT PHARMACEUTICALS, INC.","issuer_ticker":"CNCE","issuer_name_source":null,"issuer_url":"/issuer/0001367920","owner_cik":"0001594857","owner_name":"Tung Roger D","owner_display_name":"Tung Roger D","owner_url":"/insider/0001594857","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6700.0,"shares_display":"6,700","price_per_share":3.62,"price_display":"3.62","price_state":"stated","total_value":24254.0,"total_display":"24,254.00","total_whole":"24,254","shares_owned_after":808578.0,"shares_owned_after_display":"808,578","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-13","filed_date":"2021-12-15","scope":"insider"},{"id":4554058,"accession":"0001209191-21-011621","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-011621","line_url":"/filing/0001209191-21-011621#line-1","is_derivative":false,"issuer_cik":"0001367920","issuer_name":"CONCERT PHARMACEUTICALS, INC.","issuer_ticker":"CNCE","issuer_name_source":null,"issuer_url":"/issuer/0001367920","owner_cik":"0001594857","owner_name":"Tung Roger D","owner_display_name":"Tung Roger D","owner_url":"/insider/0001594857","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13480.0,"shares_display":"13,480","price_per_share":7.2,"price_display":"7.20","price_state":"stated","total_value":97056.0,"total_display":"97,056.00","total_whole":"97,056","shares_owned_after":808578.0,"shares_owned_after_display":"808,578","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-17","filed_date":"2021-02-17","scope":"insider"},{"id":2665227,"accession":"0001209191-16-119542","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-119542","line_url":"/filing/0001209191-16-119542#line-1","is_derivative":false,"issuer_cik":"0001367920","issuer_name":"CONCERT PHARMACEUTICALS, INC.","issuer_ticker":"CNCE","issuer_name_source":null,"issuer_url":"/issuer/0001367920","owner_cik":"0001594857","owner_name":"Tung Roger D","owner_display_name":"Tung Roger D","owner_url":"/insider/0001594857","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":19610.0,"shares_display":"19,610","price_per_share":10.55,"price_display":"10.55","price_state":"stated","total_value":206885.5,"total_display":"206,885.50","total_whole":"206,886","shares_owned_after":538965.0,"shares_owned_after_display":"538,965","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-11","filed_date":"2016-05-12","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":6,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":5,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":6},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001367920","name":"CONCERT PHARMACEUTICALS, INC.","url":"/issuer/0001367920","role":"Director, Officer (Chief Executive Officer)","n_filings":6,"first_seen":"2016-05-12","last_seen":"2023-01-09"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001594857","retrieved_at":"2026-08-24T09:47:13+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}